These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 27307291)
1. Regulatory T Cell Therapy for Ischemic Stroke: how far from Clinical Translation? Xia Y; Cai W; Thomson AW; Hu X Transl Stroke Res; 2016 Oct; 7(5):415-9. PubMed ID: 27307291 [No Abstract] [Full Text] [Related]
2. Cell therapy for ischemic stroke: Are differences in preclinical and clinical study design responsible for the translational loss of efficacy? Cui LL; Golubczyk D; Tolppanen AM; Boltze J; Jolkkonen J Ann Neurol; 2019 Jul; 86(1):5-16. PubMed ID: 31020699 [No Abstract] [Full Text] [Related]
3. Interleukin-2 Mediated Expansion of T-Regulatory Cells as an Ischemic Stroke Therapy. Hurst DA; Sohrabji F Stroke; 2024 Jun; 55(6):e159-e160. PubMed ID: 38787931 [No Abstract] [Full Text] [Related]
4. Different treatment settings of Granulocyte-Colony Stimulating Factor and their impact on T cell-specific immune response in experimental stroke. Dietel B; Cicha I; Achenbach S; Kollmar R; Garlichs C; Tauchi M Immunol Lett; 2014; 158(1-2):95-100. PubMed ID: 24333341 [TBL] [Abstract][Full Text] [Related]
6. Targeting lymphocytes in ischemic stroke. Ducruet AF; Connolly ES World Neurosurg; 2011; 76(3-4):212-4. PubMed ID: 21986406 [No Abstract] [Full Text] [Related]
7. Uncovering the Rosetta Stone: Report from the First Annual Conference on Key Elements in Translating Stroke Therapeutics from Pre-Clinical to Clinical. Bix GJ; Fraser JF; Mack WJ; Carmichael ST; Perez-Pinzon M; Offner H; Sansing L; Bosetti F; Ayata C; Pennypacker KR Transl Stroke Res; 2018 Jun; 9(3):258-266. PubMed ID: 29633156 [TBL] [Abstract][Full Text] [Related]
8. Current Opinion of Bone Marrow Stromal Cell Transplantation for Ischemic Stroke. Kuroda S Neurol Med Chir (Tokyo); 2016 Jun; 56(6):293-301. PubMed ID: 26984453 [TBL] [Abstract][Full Text] [Related]
9. Stem Cells as an Emerging Paradigm in Stroke 4: Advancing and Accelerating Preclinical Research. Boltze J; Modo MM; Mays RW; Taguchi A; Jolkkonen J; Savitz SI; Stroke; 2019 Nov; 50(11):3299-3306. PubMed ID: 31658004 [No Abstract] [Full Text] [Related]
11. Can molecular and cellular neuroprotection be translated into therapies for patients?: yes, but not the way we tried it before. Tymianski M Stroke; 2010 Oct; 41(10 Suppl):S87-90. PubMed ID: 20876514 [TBL] [Abstract][Full Text] [Related]
12. Understanding and managing ischemic stroke. Barber PA; Auer RN; Buchan AM; Sutherland GR Can J Physiol Pharmacol; 2001 Mar; 79(3):283-96. PubMed ID: 11294605 [TBL] [Abstract][Full Text] [Related]
14. Concise review: Preclinical studies on human cell-based therapy in rodent ischemic stroke models: where are we now after a decade? Leong WK; Lewis MD; Koblar SA Stem Cells; 2013 Jun; 31(6):1040-3. PubMed ID: 23390084 [TBL] [Abstract][Full Text] [Related]
15. Endovascular Therapy for Acute Ischemic Stroke: Dawn of a New Era. Alberts MJ; Shang T; Magadan A JAMA Neurol; 2015 Oct; 72(10):1101-3. PubMed ID: 26237199 [No Abstract] [Full Text] [Related]
17. Challenges and research progress of the use of mesenchymal stem cells in the treatment of ischemic stroke. Jiang J; Wang Y; Liu B; Chen X; Zhang S Brain Dev; 2018 Aug; 40(7):612-626. PubMed ID: 29661589 [TBL] [Abstract][Full Text] [Related]